Table 1.
Important potential interactions between herbal preparations and conventional drugs*
| Herb | Conventional drug | Potential problem |
|---|---|---|
| Echinacea used longer than 8 wks |
Anabolic steroids, methotrexate, amiodarone, ketoconazole |
Hepatotoxicity |
| Feverfew |
Nonsteroidal anti-inflammatory drugs |
Inhibition of herbal effect |
| Feverfew, garlic, ginseng, ginko, ginger |
Warfarin sodium |
Altered bleeding time |
| Ginseng |
Phenelzine sulfate |
Headache, tremulousness, manic episodes |
| Ginseng |
Estrogens, corticosteroids |
Additive effects |
| St John's wort |
Monoamine oxidase inhibitor and serotonin reuptake inhibitor antidepressants |
Mechanism of herbal effect uncertain. Insufficient evidence of safety with concomitant use—therefore not advised |
| St John's wort |
Antiretrovirals, digoxin, theophylline, cyclosporin, oral contraceptives |
Decreased clinical effect |
| Valerian |
Barbiturates |
Additive effects, excessive sedation |
| Kyushin, licorice, plantain, uzara root, hawthorn, ginseng |
Digoxin |
Interference with pharmacodynamics and drug level monitoring |
| Evening primrose oil, borage |
Anticonvulsants |
Lowered seizure threshold |
| Shankapulshpi (Ayurvedic preparation) |
Phenytoin |
Reduced drug levels, inhibition of drug effect |
| Kava kava |
Benzodiazepines |
Additive sedative effects, coma |
| Echinacea, zinc (immunostimulants) |
Immunosuppressants (such as corticosteroids, cyclosporin) |
Antagonistic effects |
| Kelp |
Thyroxine |
Iodine content of herb may interfere with thyroid replacement |
| Licorice |
Spironolactone |
Antagonism of diuretic effect |
| Karela, ginseng | Insulin, sulfonylureas, biguanides | Altered glucose concentrations. These herbs should not be prescribed in diabetic patients |
Data from Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200-2211.